@prefix p: <http://www.wikidata.org/prop/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema1: <http://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix wds: <http://www.wikidata.org/entity/statement/> .
@prefix wdt: <http://www.wikidata.org/prop/direct/> .
@prefix wdtn: <http://www.wikidata.org/prop/direct-normalized/> .
@prefix wikibase: <http://wikiba.se/ontology#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

wd:Q413299 rdfs:label "بيفاسيزوماب"@ar,
        "بواسیزامب"@azb,
        "বেভাসিজুমাব"@bn,
        "bevacizumab"@ca,
        "bevacizumab"@cs,
        "Bevacizumab"@de,
        "βεβασιζουμάμπη"@el,
        "bevacizumab"@en,
        "Bevacizumab"@es,
        "Bevatsisumaab"@et,
        "بواسیزامب"@fa,
        "bevasitsumabi"@fi,
        "bevacizumab"@fr,
        "אווסטין"@he,
        "बेवाकिज़ुमैब"@hi,
        "bevacizumab"@hr,
        "Բևացիզումաբ"@hy,
        "Bevasizumab"@id,
        "Bevacizumab"@it,
        "ベバシズマブ"@ja,
        "베바시주맙"@ko,
        "bevacizumab"@nb,
        "bevacizumab"@nl,
        "bevacizumab"@nn,
        "ବେଭାସିଜୁମାବ"@or,
        "bewacizumab"@pl,
        "bevacizumab"@pt,
        "bevacizumab"@ro,
        "бевацизумаб"@ru,
        "Bevacizumab"@sh,
        "bevacizumab"@sl,
        "бевацизумаб"@sr,
        "Бевацизумаб"@sr-ec,
        "Bevacizumab"@sr-el,
        "bevacizumab"@sv,
        "เบวะซิซิวแมบ"@th,
        "Bevasizumab"@tr,
        "бевацизумаб"@uk,
        "Bevacizumab"@vi,
        "贝伐珠单抗"@zh,
        "贝伐珠单抗"@zh-cn,
        "贝伐珠单抗"@zh-hans,
        "貝伐珠單抗"@zh-hant ;
    schema1:dateModified "2026-11-04T17:27:12+00:00"^^xsd:dateTime ;
    schema1:description "chemiese verbinding"@af,
        "compuesto quimico"@an,
        "مركب كيميائي"@ar,
        "compuestu químicu"@ast,
        "ফার্মাসিউটিক্যাল ড্রাগ"@bn,
        "compost químic"@ca,
        "chemická sloučenina"@cs,
        "kemisk forbindelse"@da,
        "monoklonaler Antikörper, Protein, Arzneimittel"@de,
        "chemische Verbindung"@de-ch,
        "φάρμακο"@el,
        "pharmaceutical drug"@en,
        "chemical compound"@en-ca,
        "chemical compound"@en-gb,
        "kemia kombinaĵo"@eo,
        "compuesto químico"@es,
        "konposatu kimiko"@eu,
        "kemiallinen yhdiste"@fi,
        "protéine"@fr,
        "composto químico"@gl,
        "תרכובת"@he,
        "औषधीय औषधि"@hi,
        "քիմիական միացություն"@hy,
        "senyawa kimia"@id,
        "farmaco"@it,
        "分子標的治療薬の一つ"@ja,
        "수많은 유형의 암과 특정 눈병을 치료하기 위해 사용되는 약물"@ko,
        "کیٖمیٲیی مُرَکَب"@ks,
        "compositum chemicum"@la,
        "cheemesch Verbindung"@lb,
        "ķīmisks savienojums"@lv,
        "kjemisk forbindelse"@nb,
        "chemische verbinding"@nl,
        "kjemisk sambinding"@nn,
        "component quimic"@oc,
        "związek chemiczny"@pl,
        "medicamento"@pt,
        "composto químico"@pt-br,
        "compus chimic"@ro,
        "chemická zlúčenina"@sk,
        "proteinë"@sq,
        "farmasötik ilaç"@tr,
        "Thuốc y dược"@vi,
        "药物"@zh ;
    schema1:version 2564772932 ;
    wikibase:identifiers 36 ;
    wikibase:sitelinks 32 ;
    wikibase:statements 83 ;
    skos:altLabel "Avastin"@de,
        "μπεβασιζουμάμπη"@el,
        "12-IGG1"@en,
        "Avastin"@en,
        "R-435"@en,
        "RG-435"@en,
        "Rhumab-VEGF"@en,
        "antiVEGF"@en,
        "Avastin"@es,
        "Avastin"@fi,
        "בווציזומאב"@he,
        "avastin"@hr,
        "アバスチン"@ja,
        "ベバシツマブ"@ja,
        "ベヴァシズマブ"@ja,
        "bevakizumab"@nn,
        "ଆଭାଷ୍ଟିନ"@or,
        "Avastin"@pt,
        "Bevacizumab"@pt,
        "Bevacizumabe"@pt,
        "Авастин"@ru,
        "Avastin"@sh,
        "Avastin"@sl,
        "Avastin"@sr,
        "Altuzan"@tr,
        "安维汀®"@zh,
        "癌思停®"@zh,
        "达攸同®"@zh ;
    p:P10245 wds:Q413299-07ebe740-4559-f8e6-a973-9cd60fb4b4ab ;
    p:P10283 wds:Q413299-CE402A8B-944A-487F-AFC9-DC9BC504F151 ;
    p:P10376 wds:Q413299-18E3190A-4774-4D81-AE7F-F8431A5D5482,
        wds:Q413299-19DD2D68-5769-4E2E-B049-316D97C55BA8,
        wds:Q413299-2AC35C50-2E5C-4708-9D7F-C966934BBE42,
        wds:Q413299-7B1C45AE-44F8-4F44-A7DD-38CDF3B7E5D9,
        wds:Q413299-D0826CB3-DF50-463B-A00A-2FF889FC4BFD,
        wds:Q413299-D55BE695-7CF6-4DA5-B088-D25276BFA890 ;
    p:P11143 wds:Q413299-46D1275D-261E-4F20-9CEB-896D9DC87924 ;
    p:P1417 wds:Q413299-21798964-CB34-4276-AE6D-6E49D636A84D ;
    p:P2062 wds:Q413299-EDACF729-18EC-4201-8675-B4C2C706179E ;
    p:P2067 wds:Q413299-c200ca3f-42cc-c30b-5167-a0f4174354fc ;
    p:P2115 wds:Q413299-3384F5B4-B57F-415F-83C8-163F0F9991F7 ;
    p:P2175 wds:Q413299-038D4296-3CD7-4D5D-BACA-430235035BE2,
        wds:Q413299-11CBF5C9-7534-424B-BB24-8E4CBD2148B1,
        wds:Q413299-2309DCE2-660A-44C2-A703-4982C1DE108E,
        wds:Q413299-2E357056-982E-4E0B-BF13-9A53B30CF687,
        wds:Q413299-2E39A069-59A2-488F-8FA2-2718B1FD5B8B,
        wds:Q413299-312BBA4A-C8FB-446B-A0C9-6789116C464A,
        wds:Q413299-3405DF08-D475-4E02-A241-1C4A27F3C77A,
        wds:Q413299-472AFDDB-CA35-4830-9E29-334C474AC9A8,
        wds:Q413299-4E4EDB8B-5D3E-4B02-8575-34F6C2E0E373,
        wds:Q413299-4FFA64D3-FC24-442F-8DF2-5F39E15F6C90,
        wds:Q413299-5D8BDACD-728D-4B67-B617-78EB2EF98098,
        wds:Q413299-6CA9728C-62C2-495B-A671-8CA4E32CAD64,
        wds:Q413299-6D99168A-7CAE-45FE-ACA5-6EB3BEE31E3D,
        wds:Q413299-7724AECB-C1DF-4DDD-B7AB-37364A28AD91,
        wds:Q413299-7834A635-7047-4224-9339-5F21B92C1120,
        wds:Q413299-7A1EA8DF-0896-4CC7-B7BF-F8499149CC22,
        wds:Q413299-7D695471-585B-4D08-BCA2-F3CD4F014D1A,
        wds:Q413299-87FE461B-89B0-42E8-93DC-115B1DC997F5,
        wds:Q413299-90D0CE0F-37E6-483B-8A09-EE6972B4ED22,
        wds:Q413299-96C37203-86D8-489B-B4BF-7E6360353469,
        wds:Q413299-AA7FD32D-35FC-4377-B8F0-2285A9A3F046,
        wds:Q413299-AE18CB52-9E8A-472D-B714-002FD433D6F7,
        wds:Q413299-B70C40A0-6160-4563-A975-77C324C4AC75,
        wds:Q413299-C12C91FC-3261-4D56-A063-BADBAAC40B3B,
        wds:Q413299-C212E41F-1DB6-4815-B691-E13248539F6D,
        wds:Q413299-C803BAD7-75B4-42BE-84DB-57BF7340DAC6,
        wds:Q413299-CFF87F11-E4F6-409E-8D5D-B81735E363B2,
        wds:Q413299-DB717C7F-74EC-4160-AF56-5AFA1105033D,
        wds:Q413299-ED5047AB-F913-46A8-98E5-46F5DF127A2B,
        wds:Q413299-EE895596-BDD2-4CA9-8A77-8FA7F1FC9163,
        wds:Q413299-f21b9154-4dad-8397-47f1-53cefa708cbe ;
    p:P2275 wds:Q413299-6EB4B3F3-CDB5-4C28-9661-6785AFF74847 ;
    p:P231 wds:Q413299-53C88FC5-CE53-4B23-88AC-9ADE1C1332CC ;
    p:P2347 wds:Q413299-31F8F94E-CB4B-422C-AF82-5C9570458776 ;
    p:P267 wds:Q413299-C30DE4D4-C41C-4324-AF36-8069559F6D59 ;
    p:P274 wds:Q413299-c83d1e08-47f0-33c3-3e78-0c357c32cb95 ;
    p:P279 wds:Q413299-7EC58568-8CA2-40A4-83E7-695052969705 ;
    p:P2868 wds:Q413299-3155CB90-37EB-4C25-987F-CF5287562F6B,
        wds:Q413299-36AE8EF0-69B1-4895-9474-8C11A99214C5,
        wds:Q413299-60CE64B3-0AE5-49EB-83D6-E2336D0150E5,
        wds:Q413299-6551C3A8-F82F-4D0B-8637-0FED18C72901,
        wds:Q413299-DBABFE45-4261-4CE3-9D71-C4DAFB43EA97,
        wds:Q413299-F223A031-8B03-48A8-B30F-6EC0D16D5F95 ;
    p:P2892 wds:Q413299-AC47EE7E-15DF-4ABB-A64E-52045D5C9320 ;
    p:P31 wds:Q413299-554D8A8E-8963-4988-BC5F-E7E2BCD6EAB4 ;
    p:P3221 wds:Q413299-1F1982ED-7E58-48EA-8BC3-B8D4AFB02592 ;
    p:P3345 wds:Q413299-4F8F87C1-0437-455F-9980-F023815F4209 ;
    p:P3417 wds:Q413299-AF7D4EAB-4303-4BE2-8E58-E8CC1268D6AF ;
    p:P3489 wds:Q413299-BCE9BFFC-E31D-49DF-878E-29BEA9E6AB91 ;
    p:P366 wds:Q413299-9A618EFE-EA60-451D-88DD-0876D7E90050,
        wds:Q413299-BDF31449-A984-4C36-8705-3617127A3BCD ;
    p:P373 wds:Q413299-479E5DB2-8B8B-433D-BE40-87171F41DCDE ;
    p:P3780 wds:Q413299-352FC030-B361-4CC3-A409-8B6D5F48A7B8 ;
    p:P4235 wds:Q413299-20DF6672-D543-4EE7-8245-491795ABA85C ;
    p:P4527 wds:Q413299-FE8E2485-1789-45A1-ABAF-BBAF26FCA23C ;
    p:P486 wds:Q413299-9AEB8392-782A-4531-ABDF-3F5CC8E02603 ;
    p:P592 wds:Q413299-1ECD54C4-CE58-4D80-9539-12A5D13963D5 ;
    p:P595 wds:Q413299-45be9765-4f1d-c879-62ad-474d732bb913 ;
    p:P6366 wds:Q413299-169B09DA-E890-4F6A-AC1A-255303615E02,
        wds:Q413299-F43AEF9B-7854-4A19-AE15-47196F1F442C ;
    p:P646 wds:Q413299-A9607143-2EE7-4EA8-A72D-C30456271331 ;
    p:P652 wds:Q413299-31C24381-D2C0-4693-B120-55419C79BE42 ;
    p:P665 wds:Q413299-CD3C0AD2-3CF5-4FD9-BABF-AB13910DA87E ;
    p:P672 wds:Q413299-2baf8423-4cdd-9df9-f2f7-034c141895da,
        wds:Q413299-9cbcf6b4-4348-ea8b-b5e0-127bd78e0a3b,
        wds:Q413299-efa6b2c1-477a-b770-179c-66f1e12aaa01 ;
    p:P715 wds:Q413299-EF2DF423-D0AC-4BCC-B35E-A47DCD86134B ;
    p:P7524 wds:Q413299-09F6B9E5-3072-406C-AF90-232EF4FBB5F1 ;
    p:P9272 wds:Q413299-3699B8CE-1DF1-4EBB-8765-9A99DFA518AD ;
    p:P9635 wds:Q413299-F6343EEA-CFDB-40EA-B26E-4620207A6003 ;
    wdtn:P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148845> ;
    wdtn:P2347 <http://www.yso.fi/onto/yso/p39032> ;
    wdtn:P4527 <http://data.parliament.uk/terms/433902> ;
    wdtn:P486 <http://id.nlm.nih.gov/mesh/D000068258> ;
    wdtn:P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201583> ;
    wdtn:P6366 <https://makg.org/entity/2777802072>,
        <https://makg.org/entity/2910640057> ;
    wdtn:P665 <http://www.kegg.jp/entry/D06409> ;
    wdtn:P672 <http://id.nlm.nih.gov/mesh/D12.776.124.486.485.114.224.060.375>,
        <http://id.nlm.nih.gov/mesh/D12.776.124.790.651.114.224.060.438>,
        <http://id.nlm.nih.gov/mesh/D12.776.377.715.548.114.224.200.438> ;
    wdt:P10245 "a607001" ;
    wdt:P10283 "C2777802072" ;
    wdt:P10376 "agricultural-and-biological-sciences/bevacizumab",
        "biochemistry-genetics-and-molecular-biology/bevacizumab",
        "immunology-and-microbiology/bevacizumab",
        "medicine-and-dentistry/bevacizumab",
        "nursing-and-health-professions/bevacizumab",
        "pharmacology-toxicology-and-pharmaceutical-science/bevacizumab" ;
    wdt:P11143 "Bevacizumab" ;
    wdt:P1417 "topic/bevacizumab" ;
    wdt:P2062 "8080" ;
    wdt:P2067 149000.0 ;
    wdt:P2115 "N0000148845" ;
    wdt:P2175 wd:Q1164529,
        wd:Q123750979,
        wd:Q1734755,
        wd:Q180614,
        wd:Q1813737,
        wd:Q18553565,
        wd:Q18553965,
        wd:Q18554882,
        wd:Q18554884,
        wd:Q18554913,
        wd:Q18554948,
        wd:Q18554959,
        wd:Q18555025,
        wd:Q18555055,
        wd:Q18555196,
        wd:Q18556109,
        wd:Q18556331,
        wd:Q18556538,
        wd:Q18975855,
        wd:Q2739660,
        wd:Q3041498,
        wd:Q3242950,
        wd:Q3658562,
        wd:Q486092,
        wd:Q504775,
        wd:Q55345659,
        wd:Q55790826,
        wd:Q56014392,
        wd:Q6084258,
        wd:Q631361,
        wd:Q9303627 ;
    wdt:P2275 "bevacizumab"@en ;
    wdt:P231 "216974-75-3" ;
    wdt:P2347 "39032" ;
    wdt:P267 "L01XC07" ;
    wdt:P274 "C₆₆₃₈H₁₀₁₆₀N₁₇₂₀O₂₁₀₈S₄₄" ;
    wdt:P279 wd:Q11173 ;
    wdt:P2868 wd:Q35456,
        wd:Q422248,
        wd:Q50429626,
        wd:Q55427776,
        wd:Q574834 ;
    wdt:P2892 "C0796392" ;
    wdt:P31 wd:Q113145171 ;
    wdt:P3221 "subject/avastin-drug" ;
    wdt:P3345 "253337" ;
    wdt:P3417 "Bevacizumab" ;
    wdt:P3489 wd:Q28123617 ;
    wdt:P366 wd:Q12140,
        wd:Q679692 ;
    wdt:P373 "Bevacizumab" ;
    wdt:P3780 wd:Q29004870 ;
    wdt:P4235 "bevacizumab" ;
    wdt:P4527 "433902" ;
    wdt:P486 "D000068258" ;
    wdt:P592 "CHEMBL1201583" ;
    wdt:P595 "6771" ;
    wdt:P6366 "2777802072",
        "2910640057" ;
    wdt:P646 "/m/0584_3" ;
    wdt:P652 "2S9ZZM9Q9V" ;
    wdt:P665 "D06409" ;
    wdt:P672 "D12.776.124.486.485.114.224.060.375",
        "D12.776.124.790.651.114.224.060.438",
        "D12.776.377.715.548.114.224.200.438" ;
    wdt:P715 "DB00112" ;
    wdt:P7524 "bevacizumab" ;
    wdt:P9272 "55974" ;
    wdt:P9635 "238" .